Search results
Tornado outbreak: Strong tornadoes hit Oklahoma after dark causing damage, injuries
The Oklahoman via Yahoo News· 4 days agoPower outages reported in southwestern Oklahoma A dangerous thunderstorm has left more than 1,000...
CDC says it’s identified 1st documented cases of HIV transmitted through cosmetic needles
WJTV Jackson· 2 days agoALBUQUERQUE, N.M. (AP) — Three women who were diagnosed with HIV after getting “vampire facial”...
Cubs, Mets each allow 1 run in 5 innings, Cubs end up falling short
CBS News· 6 hours agoThe teams were hitless in six plate appearances with runners in scoring position against the...
The USDA is testing ground beef for bird flu. Experts are confident the meat supply is safe
WMBD - FOX 43 Peoria· 11 hours agoThe U.S. Department of Agriculture will test ground beef for bird flu particles, though officials...
The iPhone 16 could get the iPhone 15's funky color-infused glass finish
TweakTown· 15 hours agoA new rumor has backed up previous claims the iPhone 16 would use the same color-infused back glass...
Mizzou baseball beats Lindenwood 13-1 in seven innings
KOMU Columbia· 6 hours agoMizzou allowed just one run in their win on Tuesday, and the offense hit two home-runs
It’s a big week for the 2024 St. Jude Dream Home; Open house tours start Saturday, May 4
NBC 10 - FOX 14 Monroe· 6 hours agoMONROE, LA (4/30/24)– We are officially one month away from giving away the 2024 St. Jude Dream Home...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
WFRV 5 Green Bay· 6 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study. First-in-class ...
'The Physics Bus' rolls into the City Museum
KSDK St. Louis· 6 days agoThe traveling science exhibit uses everyday objects to create hands-on experiences that teach physics while you play. From a door knob powering an old...
BioInvent to Present Clinical Data from its Two Leading Assets at ASCO 2024
Digital Journal· 7 days ago"We are very pleased to be chosen to present data from our two lead candidates, BI-1808 (anti-TNFR2) and BI-1206 (anti-FccgRIIB) at ASCO 2024. Our research suggests that each of these first-in-class ...